Vaxxinity, Inc.
General ticker "VAXX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1M (TTM average)
Vaxxinity, Inc. follows the US Stock Market performance with the rate: 1.5%.
Estimated limits based on current volatility of 86.0%: low 0.00$, high 0.02$
Factors to consider:
- Total employees count: 76 (-14.6%) as of 2022
- Top business risk factors: Clinical trial delays, Intellectual property risks, Regulatory and compliance, Reimbursement risks, Manufacturing complexity
- Current price 98.6% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.37$, 1.16$]
- 2024-12-30 to 2025-12-30 estimated range: [0.36$, 1.08$]
Financial Metrics affecting the VAXX estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -55.81 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 30.26 <= 41.86
- Positive: Investing cash flow per share per price, % of 28.13 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -100 <= -0.75
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term VAXX quotes
Long-term VAXX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.00MM | $0.00MM |
| Operating Expenses | $125.14MM | $75.98MM | $58.28MM |
| Operating Income | $-125.08MM | $-75.98MM | $-58.28MM |
| Non-Operating Income | $-12.10MM | $0.76MM | $1.35MM |
| Interest Expense | $0.84MM | $0.51MM | $0.70MM |
| R&D Expense | $71.38MM | $47.63MM | $35.90MM |
| Income(Loss) | $-137.18MM | $-75.22MM | $-56.93MM |
| Profit(Loss)* | $-137.18MM | $-75.21MM | $-0.06MM |
| Stockholders Equity | $128.62MM | $62.18MM | $13.41MM |
| Inventory | $0.00MM | $6.12MM | $0.00MM |
| Assets | $166.67MM | $106.40MM | $44.31MM |
| Operating Cash Flow | $-80.99MM | $-55.93MM | $-57.24MM |
| Capital expenditure | $1.32MM | $1.87MM | $0.80MM |
| Investing Cash Flow | $-1.32MM | $-54.39MM | $28.84MM |
| Financing Cash Flow | $196.17MM | $-0.17MM | $-1.14MM |
| Earnings Per Share** | $-1.09 | $-0.60 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.